initial public offerings (IPOs) trading on American exchanges

Friday, December 6, 2024

Pulse Biosciences (PLSE) : 8-year performance

Pulse Biosciences CEO Burke T. Barrett to resign, effective today; also to resign from Board
  • The Company's Chief Commercial Officer, Kevin P. Danahy, and its Chief Technology Officer, Darrin R. Uecker, will serve as the Company's principal executive and principal financial officers until such time as the Company has identified a chief executive officer to replace Mr. Barrett.
  • Messrs. Danahy and Uecker have both served as the Company's Chief Executive Officer at different times before Mr. Barrett.




3 days later


No comments:

Post a Comment